Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAR446959 in knee osteoarthritis
NCT06704932Phase 1Completed
- Sponsor
- Sanofi
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in osteoarthritis (OA) comparing SAR446959 with Placebo (2 arms). Primary endpoints: Adverse Events and Potentially Clinically Significant Abnormalities. Started Nov 2024; status: completed.
02
Drugs
SAR446959
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT06704932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06704932.